Biblioteca Humberto Rosselli Quijano
Información del autor
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
[artículo]
| Título : |
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder : A placebo-controlled, multicenter study |
| Tipo de documento: |
texto impreso |
| Autores: |
Atul C. Pande, Autor ; Douglas E. Feltner, Autor ; James W. Jefferson, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 141-149 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Ansiolíticos, Ansiedad, Pregabalina, Trastornos del comportamiento social, Aumento de peso - efectos de medicamentos. |
| Resumen: |
Pregabalin is a novel compound in the development for the treatment of anxiety disorders. The safety and efficacy of pregabalin for the treatment of social anxiety disorder was evaluated in a double-blind, multicenter clinical trial in which 135 patients were randomized to 10 weeks of double-blind treatment with either pregabalin 150 mg/d, pregabalin 600 mg/d, or placebo. |
| Link: |
./index.php?lvl=notice_display&id=30962 |
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 2 (Abril) . - pp. 141-149
|
[artículo]
| Título : |
Placebo-controlled study of gabapentin treatment of panic disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
Atul C. Pande, Autor ; Mark H. Pollack, Autor ; Jerri G. Crockatt, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 467-471 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Agorafobia, Aminas, Ansiolíticos, Ácidos ciclohexanocarboxílicos, Gabapentina, Trastorno de pánico, Características sexuales. |
| Resumen: |
A randomized, double-blind, placebo-controlled, parallel-group study was conducted to evaluate the efficacy and safety of gabapentin in relieving the symptoms of panic disorder. One hundred three patients were randomly assigned to receive double-blind treatment with either gabapentin (dosed flexibly between 600 and 3,600 mg/day) or placebo for 8 weeks. |
| Link: |
./index.php?lvl=notice_display&id=31183 |
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 4 (Agosto) . - pp. 467-471
[artículo] Placebo-controlled study of gabapentin treatment of panic disorder [texto impreso] / Atul C. Pande, Autor ; Mark H. Pollack, Autor ; Jerri G. Crockatt, Autor . - 2023 . - pp. 467-471. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 4 (Agosto) . - pp. 467-471
| Palabras clave: |
Agorafobia, Aminas, Ansiolíticos, Ácidos ciclohexanocarboxílicos, Gabapentina, Trastorno de pánico, Características sexuales. |
| Resumen: |
A randomized, double-blind, placebo-controlled, parallel-group study was conducted to evaluate the efficacy and safety of gabapentin in relieving the symptoms of panic disorder. One hundred three patients were randomly assigned to receive double-blind treatment with either gabapentin (dosed flexibly between 600 and 3,600 mg/day) or placebo for 8 weeks. |
| Link: |
./index.php?lvl=notice_display&id=31183 |
|
